Combo of Several Meds at Smaller Doses May Boost HTN Care

Share this content:
Combo of Several Meds at Smaller Doses May Boost HTN Care
Combo of Several Meds at Smaller Doses May Boost HTN Care

TUESDAY, June 6, 2017 (HealthDay News) -- Combining low doses of several different antihypertensive medications may be better than using a standard dose of just one drug, according to a review published online June 5 in Hypertension.

Anthony Rodgers, M.D., Ph.D., a professor of global health at the George Institute for Global Health and University of New South Wales in Sydney, and colleagues reviewed 42 studies involving ultra-low doses of multiple medications.

According to the researchers, combining quarter doses of two drugs was as effective as a single standard dose of one blood pressure-lowering medication. A combination of four medications -- each at one-quarter dose -- was nearly twice as effective as one drug at the standard dose, they found. In general, all of the quarter-dose combinations reduced systolic and diastolic blood pressure by several points compared to a placebo. One study of quarter doses of four medications combined found that the combination reduced systolic blood pressure by 22.4 points and diastolic by 13.1 points, on average, compared to a placebo, the researchers reported.

"In terms of adverse events, single and dual quarter-dose therapy was not significantly different from placebo and had significantly fewer adverse events compared with standard-dose monotherapy," the authors write. "Quarter-dose combinations could provide improvements in efficacy and tolerability of blood pressure-lowering therapy."

Several authors disclosed financial ties to the pharmaceutical industry; two authors are named on pending patents related to the research.

Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

NIH Panel Will No Longer Review Gene Therapy Experiments

NIH Panel Will No Longer Review Gene Therapy ...

FDA will now assess gene therapy experiments and products as it does with other treatments, drugs

Doctors Remove Contact Lens Embedded in Eyelid for Years

Doctors Remove Contact Lens Embedded in Eyelid for ...

Lens was encapsulated within the upper eyelid soft tissue since childhood eye trauma

CDC: Brucellosis in Dogs Remains a Public Health Risk

CDC: Brucellosis in Dogs Remains a Public Health ...

Infection is under-recognized, may remain a threat without stronger intervention measures

is free, fast, and customized just for you!




Already a member?

Sign In Now »